| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +34% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +44% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,336.40 +10.80 (0.46%) | 17,671.58 | 26.06 | 5.24 | ||
PfizerPFIZER | ₹3,638.70 -49.10 (1.33%) | 16,867.42 | 22.94 | 4.01 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,291.50 -73.00 (1.15%) | 15,918.38 | 93.84 | 18.24 | ||
Natco PharmaNATCOPHARM | ₹785.75 +3.35 (0.43%) | 15,350.14 | 13.41 | 1.46 |